new ORAL anticoagulant called Xarelto (zuh-REL-toe)

See updated information in our chart "Comparison of Oral Antithrombotics."

You'll see a new ORAL anticoagulant called Xarelto (zuh-REL-toe).

It's initially approved to prevent thrombosis after hip or knee replacement surgery. It'll also likely be approved to prevent stroke in patients with atrial fibrillation.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote